Pulmonx Corporation (LUNG) reported first-quarter 2026 results with total revenue of $20.6 million, down 8.7% year‑over‑year and slightly below the consensus estimate of $20.8 million.
On an earnings-per-share basis, diluted EPS was -0.33, a decline of 8.3% year‑over‑year, compared with an EPS estimate of -0.3332.
Market reaction: the stock was down 1.71% since the market close following the release.
Note: This financials data is sourced from a third-party provider and has not been independently verified by Quiver.
Pulmonx Corporation Insider Trading Activity
Pulmonx Corporation insiders have traded $LUNG stock on the open market 26 times in the past 6 months. Of those trades, 0 have been purchases and 26 have been sales.
Here’s a breakdown of recent trading of $LUNG stock by insiders over the last 6 months:
- GLENDON E. III FRENCH (President and CEO) has made 0 purchases and 5 sales selling 76,618 shares for an estimated $110,796.
- DANIEL P FLORIN sold 23,321 shares for an estimated $46,408
- DAVID AARON LEHMAN (GENERAL COUNSEL) has made 0 purchases and 8 sales selling 22,515 shares for an estimated $33,635.
- GEOFFREY BERAN ROSE (CHIEF COMMERCIAL OFFICER) has made 0 purchases and 8 sales selling 14,054 shares for an estimated $20,982.
- SRIKANTH RADHAKRISHNAN (Chief Science &Techn. Officer) has made 0 purchases and 4 sales selling 10,483 shares for an estimated $14,990.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.
Pulmonx Corporation Hedge Fund Activity
We have seen 49 institutional investors add shares of Pulmonx Corporation stock to their portfolio, and 59 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC removed 2,099,156 shares (-96.5%) from their portfolio in Q4 2025, for an estimated $4,639,134
- SOLEUS CAPITAL MANAGEMENT, L.P. added 2,038,323 shares (+inf%) to their portfolio in Q4 2025, for an estimated $4,504,693
- EXODUSPOINT CAPITAL MANAGEMENT, LP added 1,951,173 shares (+inf%) to their portfolio in Q4 2025, for an estimated $4,312,092
- VESTAL POINT CAPITAL, LP removed 830,000 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $1,834,300
- MORGAN STANLEY added 539,793 shares (+14.9%) to their portfolio in Q4 2025, for an estimated $1,192,942
- GSA CAPITAL PARTNERS LLP removed 351,705 shares (-46.6%) from their portfolio in Q4 2025, for an estimated $777,268
- MILLENNIUM MANAGEMENT LLC removed 306,318 shares (-91.2%) from their portfolio in Q4 2025, for an estimated $676,962
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
Pulmonx Corporation Government Contracts
We have seen $123,145 of award payments to $LUNG over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- ZEPHR VALVES: $22,414
- PROSTHETICS:IMPLANT: $20,281
- PROS - BILL ONLY - BRONCHOSCOPY: $18,840
- PULMONARY PROSTHETIC: $14,950
- VALVE- LUNG: $12,400
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
Pulmonx Corporation Analyst Ratings
Wall Street analysts have issued reports on $LUNG in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- D. Boral Capital issued a "Buy" rating on 11/13/2025
To track analyst ratings and price targets for Pulmonx Corporation, check out Quiver Quantitative's $LUNG forecast page.
Pulmonx Corporation Price Targets
Multiple analysts have issued price targets for $LUNG recently. We have seen 2 analysts offer price targets for $LUNG in the last 6 months, with a median target of $9.5.
Here are some recent targets:
- Jason Kolbert from D. Boral Capital set a target price of $14.0 on 03/05/2026
- Jon Young from Canaccord Genuity set a target price of $5.0 on 03/05/2026
